Predicting Fluid Responsiveness Using Transiently Increased Intrathoracic Pressure in Mechanically Ventilated Patients

January 15, 2020 updated by: University of California, Davis

The goal of this study is to identify in patients requiring active fluid resuscitation and mechanical ventilation for circulatory shock, can a controlled increase in intrathoracic pressure (either by positive-end expiratory pressure (PEEP) or tidal volume (TV)) predict responsiveness to additional fluid resuscitation.

We hypothesize that a temporary, physiologically-safe increase in positive-end expiratory pressure (PEEP) and/or a temporary increase in tidal volume (from 6 cc/kg predicted body weight (PBW) to 8 cc/kg PBW) in patients requiring invasive mechanical ventilation will predict fluid responsiveness based upon an assessment of the change in pulse pressure and stroke volume variation.

Study Overview

Status

Completed

Conditions

Detailed Description

Once an eligible subject is identified and written or telephone consent is obtained from the patient or surrogate as appropriate, we will record demographic data and clinical information including age, sex, height, actual body weight, predicted body weight (PBW), APACHE II on admission, primary diagnosis, reason for ICU admission, and dose of vasopressors.

Patients will be intubated and on assist-control volume ventilation receiving low tidal volumes. Sedation will be titrated per current MICU protocol to minimize patient discomfort and minimizing ventilator dyssynchrony. In keeping with standard practice, the dose of vasoactive medications will be kept constant during the intervention period. The standard practice is to titrate vasopressor therapy every five minutes, so keeping vasoactive medications constant for sixty seconds is in keeping with the standard of care. All subjects will be in an ICU setting and monitored per standard of care (vital signs, telemetry, ventilator data) by a respiratory therapist, pulmonary and critical care fellow or faculty member, and critical care nurse at the bedside throughout the entire intervention.

A point of care (POC) echocardiogram will be performed by the investigator performing the intervention in order to measure the stroke volume index (surrogate for cardiac output).

Subjects will be randomized to either undergo the PEEP challenge or tidal volume challenge first. After the initial challenge, subjects will cross over to whichever challenge has not yet been performed.

The simple changes to the ventilator we are proposing to use as challenges in this study are done frequently and routinely in the ICU with or without the supervision of a physician, but we will have a physician present throughout the entire proposed intervention. For the subjects undergoing PEEP challenge first, we will do the following:

  1. POC echocardiogram performed to measure SVI
  2. The tidal volume will be set to 6 mL/kg PBW and the patients will be monitored for 5 minutes for any variability in vital parameters. The subject's ventilatory parameters, vitals, hemodynamics, and oxygenation will be recorded on initial ventilator settings.
  3. PEEP challenge - PEEP will be increased by 50% for 60 seconds. The subject's ventilatory parameters, vitals, hemodynamics, and oxygenation will be recorded after 60 seconds.
  4. PEEP returned to initial settings.
  5. 2 minute washout period to prepare for tidal volume challenge.
  6. Tidal volume challenge - tidal volume raised to 8 cc/kg PBW for 60 seconds. The subject's ventilatory parameters, vitals, hemodynamics, and oxygenation will be recorded will be recorded after 60 seconds.
  7. Subjects ventilator settings returned to initial settings x 2 minutes.
  8. 500 cc crystalloid fluid bolus of the ICU team's choosing is then administered to the patient. The subject's ventilatory parameters, vitals, hemodynamics, and oxygenation will be measured.
  9. POC echocardiogram performed to measure SVI and determine if the subject is a fluid responder or non-responder.

The procedure for those randomized into the tidal volume challenge first will be similar, but the tidal volume challenge (e, above), rather than the PEEP challenge (b, above), will be performed first.

In the management of a critically ill patient in circulatory shock, physicians encounter the question of whether to administer fluid to the patient or not several times during the course of the patient's stay in the ICU. To ensure that our study is generalizable and applicable, we will perform the above protocol up to three times per subject. This is similar to previous studies using changes in intrathoracic pressure to predict fluid responsiveness. Additionally, we will have a larger number of interventions in order to better show a clear difference statistically.

Study Type

Interventional

Enrollment (Actual)

5

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • California
      • Sacramento, California, United States, 95817
        • University of California, Davis

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Mechanically ventilated
  • Identified by treatment team as requiring intravenous fluid bolus
  • Acute circulatory failure during admission (systolic blood pressure (SBP) ≤90 mmHg or mean arterial pressure (MAP) ≤70 mmHg or requiring vasopressors to maintain SBP >90 mmHg or MAP >70 mmHg, along with one or more of the following:
  • urinary flow ≤0.5 mL/kg/min for ≥2 hours,
  • heart rate ≥100 beats per minute
  • presence of skin mottling
  • blood lactate concentration ≥4 mmol/L

Exclusion Criteria:

  • Contraindication to fluid bolus
  • Assynchrony Index > 10%
  • Clinically significant cardiac arrhythmia
  • Severe valvular heart disease
  • Chest tubes with air leak
  • Abdominal compartment syndrome
  • Pregnancy
  • Concurrent nebulized medication or inhaled nitric oxide
  • Transthoracic echogenicity unsuitable for measuring velocity-time integral of aortic blood flow (SVI)
  • Prisoner
  • Clinical brain death
  • PEEP > 15 cmH2O

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Diagnostic
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Quadruple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: Fluid responders
Patient's identified to have a significant increase in their cardiac output following a fluid bolus.
Will transiently increase intrathoracic pressure for 60 seconds and monitor for changes in hemodynamics during this time.
Other Names:
  • PEEP Challenge
  • Tidal Volume Challenge
Other: Fluid non-responders
Patient's identified to NOT have a significant increase in their cardiac output following a fluid bolus.
Will transiently increase intrathoracic pressure for 60 seconds and monitor for changes in hemodynamics during this time.
Other Names:
  • PEEP Challenge
  • Tidal Volume Challenge

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pulse Pressure Variation
Time Frame: Following 60 seconds of intrathoracic pressure challenge
Temporary increase in intrathoracic pressure (PEEP or TV) will predict fluid responsiveness using an absolute increase in pulse pressure variation by 3% or more.
Following 60 seconds of intrathoracic pressure challenge

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Heart Rate
Time Frame: Following 60 seconds of intrathoracic pressure challenge
Temporary increase in intrathoracic pressure (PEEP or TV) will predict fluid responsiveness using an absolute decrease in heart rate by 15 beats per minute or more.
Following 60 seconds of intrathoracic pressure challenge
Mean Arterial Pressure
Time Frame: Following 60 seconds of intrathoracic pressure challenge
Temporary increase in intrathoracic pressure (PEEP or TV) will predict fluid responsiveness using an absolute decrease in MAP by 15 mmHg or more.
Following 60 seconds of intrathoracic pressure challenge
Mortality
Time Frame: 7 days
Differences in 7 day mortality between fluid responders and non-responders
7 days
Stroke Volume Variation
Time Frame: Following 60 seconds of intrathoracic pressure challenge
Temporary increase in intrathoracic pressure (PEEP or TV) will predict fluid responsiveness using an absolute increase in SVV of 4% or more.
Following 60 seconds of intrathoracic pressure challenge
End-tidal carbon dioxide
Time Frame: Following 60 seconds of intrathoracic pressure challenge
Temporary increase in intrathoracic pressure (PEEP or TV) will predict fluid responsiveness using an increase in EtCO2 by 4% or more.
Following 60 seconds of intrathoracic pressure challenge

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: John Adams, MD, Attending Physician

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 27, 2017

Primary Completion (Actual)

September 13, 2018

Study Completion (Actual)

September 13, 2018

Study Registration Dates

First Submitted

January 11, 2018

First Submitted That Met QC Criteria

January 22, 2018

First Posted (Actual)

January 29, 2018

Study Record Updates

Last Update Posted (Actual)

January 18, 2020

Last Update Submitted That Met QC Criteria

January 15, 2020

Last Verified

January 1, 2020

More Information

Terms related to this study

Other Study ID Numbers

  • 1086731

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Fluid Reponsiveness

Clinical Trials on Increase in intrathoracic pressure

Subscribe